Dr. Margaux Longuespée obtained her PhD of chemistry at the University of Strasbourg (France) in 2016. She then dedicated her activities to the development of mass spectrometric (MS) methods for clinical pharmacology and personlized medicine at the University Hospital of Heidelberg (Germany). With her expertise in therapeutic proteins and antibodies, as well as quality management in clinical laboratories, she now serves as Project Manager Quality at EYLIO. She advises and supports biotech companies throughout the development pipeline: from molecule discovery, preparation of regulatory documentation, and QP services and audits, to packaging and storage of the Investigational Medicinal Product (IMP), through to the completion of clinical trials and beyond.